| Literature DB >> 32566668 |
Jie-Yuan Jin1, Dan-Yu Liu2,3, Zi-Jun Jiao1, Yi Dong1, Jie Li1, Rong Xiang1,4.
Abstract
INTRODUCTION: Distal arthrogryposis type 5D (DA5D) is an autosomal recessive disease. The clinical symptoms include contractures of the joints of limbs, especially camptodactyly of the hands and/or feet, unilateral ptosis, a round-shaped face, arched eyebrows, and micrognathia, without ophthalmoplegia. ECEL1 is a DA5D causative gene that encodes a membrane-bound metalloprotease. ECEL1 plays important roles in the final axonal arborization of motor nerves in limb skeletal muscles and neuromuscular junction formation during prenatal development.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32566668 PMCID: PMC7273484 DOI: 10.1155/2020/2149342
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1(a) Pedigree of the DA5D family with segregation analysis. The black symbols represent an affected member, and the arrow indicates the proband. Genotypes are identified by letters and slash, with red representing mutations. (b–f) The parts of phenotypes of the proband. (b) Facial features and contractures of the wrists, elbows, and knees in the proband. The proband had the bilateral distal arthrogryposis (c, d) and the webbing of bilateral fingers (e) and elbows (f).
Variants identified by WES in combination with AMC-related gene-filtering in the present patient.
| Gene | Variant | Mutation taster | PolyPhen-2 | SIFT | 1000G | ExAC | gnomAD | OMIM clinical phenotype | American College of Medical Genetics classification∗ |
|---|---|---|---|---|---|---|---|---|---|
|
| NM_001164508: c.19295A>G, p.Q6432R | D (0.872) | D (0.985) | T (0.103) | 0.0016 | 0.0005 | 0.0004 | AR; nemaline myopathy 2 | PP3, BP5 |
|
| NM_004826: c.1810G>A, p.G604R | D (1.000) | D (1.000) | D (0.000) | — | 0.0000 | 0.0001 | AR; arthrogryposis, distal, type 5D | PM2, PP3, PP4 |
|
| NM_004826: c.69C>A, p.C23∗ | D (1.000) | — | — | — | — | — | PVS1, PM2, PP3, PP4 | |
|
| NM_198196: c.901A>G, p.I301V | P (1.000) | B (0.089) | D (0.026) | — | 0.0001 | 0.0000 | AD; C syndrome | PM2, BS4, BP4, BP5 |
|
| NM_182895: c.1796C>T, p.A599V | P (0.990) | D (0.351) | D (0.024) | — | — | — | AR; Van den Ende-Gupta syndrome | PM2, PP3, BP5 |
|
| NM_004463: c.1340+9C>T | D (1.000) | — | — | 0.0032 | 0.0008 | 0.0005 | XLR; Aarskog-Scott syndrome/XLR; mental retardation, X-linked syndromic 16 | BP4, BP5 |
D: disease causing; T: tolerated; P: polymorphism; B: benign; AR: autosomal recessive; AD: autosomal dominant; XLR: X-linked recessive. ∗Pathogenic: PVS1> PS1> …> PS4> PM1-6> PP1-5; benign: BA1> BS1-4> BP1-7. PVS: pathogenic very strong; PS: pathogenic strong; PM: pathogenic moderate; PP: pathogenic supporting; BA: benign stand alone; BS: benign strong; BP: benign supporting.
Figure 2(a) Sequencing results of the ECEL1 mutations. Sequence chromatograms indicate compound heterozygosity (NM_004826: c.69C>A, p.C23∗ and c.1810G>A, p.G604R) in the family with DA5D. (b) The mutation sites (G604R) are highly evolutionarily conserved across species. The red graph represents mutated amino acids, and the red box emphasizes these sites across species for comparison.
Figure 3ECEL1 mutations identified in DA5D patients. The rectangular box represents the ECEL1 protein with the N-terminus on the left and C-terminus on the right. Known functional domains include a cytoplasmic domain (indicated by the red box), a transmembrane domain (yellow box), and an extracellular domain (gray box) with a zinc binding motif (green box). Vertical arrows show the approximate location of mutations of ECEL1. The red words represent previous mutations.